-
OspA lipoprotein
- indication:For prophylactic treatment of Lyme Disease
- pharmacologypharmacology:
- mechanism: OspA lipoprotein, an outer surface protein of the bacteria Borrelia burgdorferi sensu stricto ZS7, is used to stimulate the production of specific antibodies against B. burgdorferi. It is used as a vaccination against Lyme Disease, a disease carried by ticks.
- toxicity:
- absorprion:
- halflife: 1.2 hours (mammalian reticulocytes, in vitro).
- roouteelimination:
- volumedistribution:
- clearance: